Regulation of transforming growth factor-β1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 3, 1998, Pages 334-342

  Gurujeyalakshmi, G ^b   Hollinger, M A ^b   Giri, S N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CRICETINAE;

BLEOMYCIN; COLLAGEN; NICOTINIC ACID; TAURINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DIET; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; LUNG FIBROSIS; LUNG LAVAGE; MALE; METABOLISM; SYRIAN HAMSTER;

ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN; CRICETINAE; DIET; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; MESOCRICETUS; NIACIN; PULMONARY FIBROSIS; TAURINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032013154     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.3.2867     Document Type: Article

References (52)

1. Crough, E. 1990. Pathophysiology of pulmonary fibrosis. Am. J. Physiol. 259:159-184.
2. Goldstein, R. H., and A. Fine. 1986. Fibrotic reactions in the lung: the activation of the lung fibroblast. Exp. Lung Res. 11:245-261.
3. Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18:29-43.
4. 3) in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 13:34-44.
5. Fine, A., and R. H. Goldstein. 1987. The effect of transforming growth factor β on cell proliferation and collagen by fibroblasts. J. Biol. Chem. 262: 3897-3902.
6. Varga, J., J. Rosenbloom, and S. A. Jimenez. 1987. Transforming growth factor-beta (TGF-β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal dermal fibroblasts. Biochem. J. 247:6443-6446.
7. Raghow, R., A. E. Postlethwaite, J. Keski-Oja, H. L. Moses, and A. H. Kang. 1987. Transforming growth factor-beta increases steady-state levels of type I procollagen and fibronectin mRNAs posttranscriptionally in human dermal fibroblasts. J. Clin. Invest. 79:1285-1288.
8. Raghu, G., S. Masta, D. Meyers, and A. S. Narayanan. 1989. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-beta. Am. Rev. Respir. Dis. 140:95-100.
9. Sporn, M. B., A. B. Roberts, L. M. Wakefield, and B. De Crombrugghe. 1987. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell Biol. 105:1039-1045.
10. Pierce, G. F., T. A. Mustoe, J. Lingelbach, V. R. Masakowski, P. Gramates, and T. F. Deuel. 1989. Transforming growth factor β reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Prof. Natl. Acad. Sci. USA 86:2229-2233.
11. Khalil, N., O. Bereznay, M. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp. Med. 170:727-737.
12. Hoyt, D. G., and J. S. Lazo. 1988. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor β precede bleomycin induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246: 765-771.
13. Raghow, R., P. Irish, and A. H. Kang. 1989. Coordinate regulation of transforming growth factor β gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 84:1836-1842.
14. 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am. J. Respir. Cell Mol. Biol. 15:252-259.
15. Giri, S. N. 1990. Pharmacologic perspective in pulmonary fibrosis research. In Focus on Pulmonary Pharmacology and Toxicology. M. A. Hollinger, editor. CRC Press, Boca Raton, FL. 19-55.
16. Banks, M. A., D. W. Porter, W. G. Martin, and V. Castranova. 1991. Ozone induced lipid peroxidation and membrane leakage in isolated rat alveolar macrophages: protective effects of taurine. J. Nutr. Biochem. 2:308-313.
17. Wang, O. J., M. A. Hollinger, and S. N. Giri. 1992. Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment. J. Pharmacol. Exp. Ther. 262:127-132.
18. Brown, O. R., M. Heitkamp, and C. S. Song. 1981. Niacin reduces paraquat toxicity in rats. Science 212:1510-1512.
19. Wang, Q., S. N. Giri, D. M. Hyde, J. M. Nakashima, and I. Javadi. 1990. Niacin attenuates bleomycin-induced lung fibrosis in the hamster. J. Biochem. Toxicol. 5:13-22.
20. Nagai, A., S. Yasui, Y. Ozawa, H. Uno, and K. Konno. 1994. Niacin attenuates acute lung injury induced by lipopolysaccharide in the hamster. Eur. Respir. J. 7:1125-1130.
21. Wang, Q., S. N. Giri, D. M. Hyde, and C. Li. 1991. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem, Pharmacol. 42:1115-1122.
22. Gurujeyalakshmi, G., S. N. Iyer, M. A. Hollinger, and S. N. Giri. 1996. Procollagen gene expression is downregulated by taurine and niacin at the transcriptional level in the bleomycin hamster model of lung fibrosis. J. Pharmacol. Exp. Ther. 277:1152-1157.
23. Gurujeyalakshmi, G., and S. N. Giri. 1995. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: down-regulation of TGF-β and procollagen I and III gene expression. Exp. Lung. Res. 21:791-808.
24. Giri, S. N., D. M. Dallas, and J. M. Nakashima. 1986. Analysis of bronchoalveolar lavage fluid from bleomycin induced pulmonary fibrosis in hamsters. Toxicol. Pathol. 14:149-157.
25. SAS Institute Inc. 1985. SAS/STAT™ Guide for Personal Computers. Version 6. SAS Institute, Inc., Cary, NC.
26. Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factors-βs. In Peptide Growth Factors and Their Receptors: Handbook of Experimental Pharmacology. Vol. 95/I. M. B. Sporn and A. B. Roberts, editors. Springer-Verlag, Heidelberg, Germany. 419-472.
27. Shaw, G. and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
28. Pettinen, R. P., S. Kobayashi, and P. Bornstein. 1988. Transforming growth factor β increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc. natl. Acad. Sci. USA 85: 1105-1108.
29. Zitnik, R. J., N. L. Whiting, and J. A. Elias. 1994. Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms. Am. J. Respir. cell Mol. Biol. 10:643-650.
30. Edwards, D., G. Murphy, J. Reynolds, S. Whitman, A. Doucherty, P. Angel, and J. Heath. 1987. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1899-1904.
31. Brockelmann, T. J., A. H. Limper, T. V. Colby, and J. A. McDonald. 1991. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 88:6642-6646.
32. Cormack, D. T., B. Porras-Reyes, and T. A. Mustoe. 1990. Current concepts in wound healing: growth factor and macrophage interaction. J. Trauma 30:S129-S133.
33. 1 regulation of extracellular matrix. Kidney Int. 41:557-559.
34. McCartney-Francis, N. L., and S. M. Wahl. 1994. Transforming growth factor β: a matter of life and death.J. Leuk. Biol. 55:401-409.
35. Breen, E., S. Shull, S. Burne, M. Absher, J. Kelley, S. Phan, and K. R. Cutroneo. 1992. Bleomycin regulation of transforming growth factor-β mRNA in rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 6:146-152.
36. 2, by primary cultures of bronchial epithelial cells. J. Clin. Invest. 90: 1379-1385.
37. Phan, S. H., M. Gharaee-Kermani, F. Wohler, and U. S. Ryan. 1991. Stimulation of rat endothelial cell transforming growrth factor-β production. J. Clin. Invest. 87:148-154.
38. McCartney-Francis, N. L., D. Mizel, H. Wong, L. Wahl, and S. Wahl. 1990. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factor 4:27-35.
39. Zhang, Y., T. C. Lee, and B. Guillemin. 1993. Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages form idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150:418-4196.
40. Vanhee, D., P. Gosset, and B. Wallaert. 1994. Mechanisms of fibrosis in coal workers pneumoconiosis: increased production of platelet-derived growth factor, insulin-like growth factor type I. and transforming growth factor-β and relationship to disease severity. Am. J. Respir. Crit. Care Med. 150: 1049-1055.
41. Shaw, R. J., S. H. Benedict, and R. A. F. Clark. 1991. Pathogenesis of pulmonary fibrosis in interstitial lung disease: alveolar macrophage PDGF(β) gene activation and up-regulation by interferon gamma. Am. Rev. Respir. Dis. 143:163-173.
42. 2. Am. J Respir. Cell. Mol. Biol. 4:397-407.
43. Giri, S. N., D. M. Hyde, and M. A. Hollinger. 1993. Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax 48:959-966.
44. 1 gene expression in rat liver. FEMS Lett. 308:267-270.
45. Dhanani, S., M. Huang, J. Wang, and S. M. Dubinett. 1994. Interferon-alpha inhibits murine macrophage transforming growth factor-beta mRNA expression. Inflammation 18:301-309.
46. Castilla, A., J. Prieto, and N. Fausto. 1991. Transforming growth factors beta 1 and alpha in chronic liver disease: effects of interferon alpha therapy. N. lEngl. J. Med. 324:933-940.
47. Martyre, M.-C., H. Magdelenat, and F. Calvo. 1991. Interferon-gamma in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myclofibrosis with mycloid metaplasia. Br. J. Haematol. 77:431-435.
48. Schuller-Levis, G., M. R. Quinn, C. Wright, and E. Park. 1994. Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action. Adv. Exp. Med. Biol. 359:31-39.
49. Schuller-Levis, G. B., R. E., Gordon, E. Park, K. J. Pendino, and D. L. Laskin. 1995. Taurine protects rat bronchioles from acute ozone-induced lung inflammation and hyperplasia. Exp. Lung Res. 21:877-888.
50. Rossi, P., G. Karsenty, A. B. Roberts, N. S. Roche, M. B. Sporn, and B. deCombrugghe. 1988. A nuclear factor 1 binding site mediates the transcription of type I collagen promoter by transforming growth factor-β. Cell 52:405-414.
51. 1 type I collagen gene. Biochem. J. 280:157-162.
52. Wang, Q., S. N. Giri, D. M. Hyde, and J. M. Nakashima. 1989. Effect of taurine on bleomycin-induced lung fibrosis in hamsters. Proc. Soc. Exp. Biol. Med. 190:330-338.